• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实施癌症临床护理路径:支付方和服务提供方合作的成功模式。

Implementation of cancer clinical care pathways: a successful model of collaboration between payers and providers.

机构信息

Cardinal Health; P4 Healthcare, Dublin, OH; Blue Cross Blue Shield of Michigan, Detroit; Physician Resource Management, Novi, MI.

出版信息

J Oncol Pract. 2012 May;8(3 Suppl):e38s-43s. doi: 10.1200/JOP.2012.000564.

DOI:10.1200/JOP.2012.000564
PMID:22942833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3348604/
Abstract

Despite rising medical costs within the US health care system, quality and outcomes are not improving. Without significant policy reform, the cost-quality imbalance will reach unsustainable proportions in the foreseeable future. The rising cost of health care in part results from an expanding aging population with an increasing number of life-threatening diseases. This is further compounded by a growing arsenal of high-cost therapies. In no medical specialty is this more apparent than in the area of oncology. Numerous attempts to reduce costs have been attempted, often with limited benefit and brief duration. Because physicians directly or indirectly control or influence the majority of medical care costs, physician behavioral changes must occur to bend the health care cost curve in a sustainable fashion. Experts within academia, health policy, and business agree that a significant paradigm change in stakeholder collaboration will be necessary to accomplish behavioral change. Such a collaboration has been pioneered by Blue Cross Blue Shield of Michigan and Physician Resource Management, a highly specialized oncology health care consulting firm with developmental and ongoing technical, analytic, and consultative support from Cardinal Health Specialty Solutions, a division of Cardinal Health. We describe a successful statewide collaboration between payers and providers to create a cancer clinical care pathways program. We show that aligned stakeholder incentives can drive high levels of provider participation and compliance in the pathways that lead to physician behavioral changes. In addition, claims-based data can be collected, analyzed, and used to create and maintain such a program.

摘要

尽管美国医疗体系中的医疗成本不断上升,但医疗质量和效果却没有得到改善。如果没有重大的政策改革,在可预见的未来,成本与质量之间的失衡将达到不可持续的程度。医疗保健成本的上升部分归因于人口老龄化的扩大,以及危及生命的疾病数量不断增加。这进一步加剧了越来越多的高成本疗法。在任何医学专业领域,这一点在肿瘤学领域表现得最为明显。为了降低成本,人们已经尝试了许多方法,但往往收效甚微,且持续时间短暂。由于医生直接或间接控制或影响着大部分医疗费用,因此必须改变医生的行为,才能以可持续的方式降低医疗成本曲线。学术界、卫生政策和商业领域的专家都认为,为了实现行为改变,利益相关者之间必须进行重大的范式转变合作。密歇根蓝十字蓝盾公司(Blue Cross Blue Shield of Michigan)和医师资源管理公司(Physician Resource Management)率先进行了这种合作,这是一家专门从事肿瘤学医疗保健咨询的公司,得到了 Cardinal Health 特种解决方案(Cardinal Health Specialty Solutions)的技术、分析和咨询支持,后者是 Cardinal Health 的一个部门。我们描述了支付方和医疗服务提供方之间在全州范围内的成功合作,以创建癌症临床护理路径项目。我们表明,利益相关者的激励措施一致可以推动高水平的提供者参与和遵守路径,从而改变医生的行为。此外,还可以收集、分析和使用基于索赔的数据来创建和维护这样的项目。

相似文献

1
Implementation of cancer clinical care pathways: a successful model of collaboration between payers and providers.实施癌症临床护理路径:支付方和服务提供方合作的成功模式。
J Oncol Pract. 2012 May;8(3 Suppl):e38s-43s. doi: 10.1200/JOP.2012.000564.
2
Implementation of cancer clinical care pathways: a successful model of collaboration between payers and providers.实施癌症临床护理路径:支付方和服务提供方合作的成功模式。
Am J Manag Care. 2012 May 1;18(5):e194-9.
3
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
4
Implementing and using quality measures for children's health care: perspectives on the state of the practice.实施和使用儿童保健质量指标:实践现状透视
Pediatrics. 2004 Jan;113(1 Pt 2):217-27.
5
Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.日本作为超老龄化社会的领跑者:来自日本医学与医疗护理的视角
Geriatr Gerontol Int. 2015 Jun;15(6):673-87. doi: 10.1111/ggi.12450. Epub 2015 Feb 5.
6
Michigan Oncology Medical Home Demonstration Project: First-Year Results.密歇根肿瘤医疗之家示范项目:第一年成果。
J Oncol Pract. 2014 Mar;10(2):104. doi: 10.1200/JOP.2013.001109.
7
Regional collaboration as a model for fostering accountability and transforming health care.区域合作作为促进问责制和变革医疗保健的一种模式。
Semin Thorac Cardiovasc Surg. 2009 Spring;21(1):12-9. doi: 10.1053/j.semtcvs.2009.03.005.
8
Private payers and cancer care: land of opportunity.私人支付者与癌症护理:机遇之地。
J Oncol Pract. 2014 Jan;10(1):15-9. doi: 10.1200/JOP.2013.000897. Epub 2013 Oct 1.
9
American Society of Clinical Oncology guidance statement: the cost of cancer care.美国临床肿瘤学会指导声明:癌症护理的成本
J Clin Oncol. 2009 Aug 10;27(23):3868-74. doi: 10.1200/JCO.2009.23.1183. Epub 2009 Jul 6.
10
Payment Reform: Unprecedented and Evolving Impact on Gynecologic Oncology.支付改革:对妇科肿瘤学产生的前所未有的且不断演变的影响
Front Oncol. 2016 Apr 15;6:84. doi: 10.3389/fonc.2016.00084. eCollection 2016.

引用本文的文献

1
Healthy days at home and prognosis of older adults with cancer and non-cancer serious life-limiting illnesses.癌症及非癌症严重危及生命疾病的老年人在家中的健康天数及预后
BMC Geriatr. 2025 Jul 3;25(1):487. doi: 10.1186/s12877-025-06160-9.
2
Enhancing patient-provider relationships with a whole person oriented healing pathway model.通过全人导向的康复路径模型加强医患关系。
BMC Health Serv Res. 2025 May 13;25(1):682. doi: 10.1186/s12913-025-12858-8.
3
Association of Patient, Physician, and Practice-Level Factors with Uptake of Payer-Led Oncology Clinical Pathways.患者、医生和实践层面因素与支付方主导的肿瘤临床路径采用的关联。
JAMA Netw Open. 2023 May 1;6(5):e2312461. doi: 10.1001/jamanetworkopen.2023.12461.
4
Cost-Effectiveness of Pharmacologic Treatment Options for Women With Endocrine-Refractory or Triple-Negative Metastatic Breast Cancer.内分泌治疗耐药或三阴性转移性乳腺癌女性的药物治疗选择的成本效益分析。
J Clin Oncol. 2023 Jan 1;41(1):32-42. doi: 10.1200/JCO.21.02473. Epub 2022 Sep 2.
5
Restructuring Skin Cancer Care in Ontario: A Provincial Plan.安大略省重塑皮肤癌护理:省级计划。
Curr Oncol. 2021 Mar 12;28(2):1183-1196. doi: 10.3390/curroncol28020114.
6
When time matters: a qualitative study on hospital staff's strategies for meeting the target times in cancer patient pathways.当时间至关重要:一项关于医院工作人员在癌症患者路径中达到目标时间的策略的定性研究。
BMC Health Serv Res. 2021 Mar 9;21(1):210. doi: 10.1186/s12913-021-06224-7.
7
Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology.提高欧洲医疗保健系统的准确性:肿瘤学中生物标志物检测未被开发的潜力。
Biomed Hub. 2020 Sep 14;5(3):182-223. doi: 10.1159/000511209. eCollection 2020 Sep-Dec.
8
A scoping review of clinical decision support tools that generate new knowledge to support decision making in real time.实时决策支持中生成新知识的临床决策支持工具的范围综述。
J Am Med Inform Assoc. 2020 Dec 9;27(12):1968-1976. doi: 10.1093/jamia/ocaa200.
9
Variations in Proton Therapy Coverage in the State of Texas: Defining Medical Necessity for a Safe and Effective Treatment.德克萨斯州质子治疗覆盖范围的差异:界定安全有效治疗的医疗必要性
Int J Part Ther. 2016 Mar;2(4):499-508. doi: 10.14338/IJPT-15-00029.1. Epub 2016 Mar 24.
10
Characterizing and assessing antiemetic underuse in patients initiating highly emetogenic chemotherapy.描述和评估起始高度致吐性化疗的患者中止吐药物的使用不足。
Support Care Cancer. 2019 Dec;27(12):4525-4534. doi: 10.1007/s00520-019-04730-3. Epub 2019 Mar 26.

本文引用的文献

1
The savings illusion--why clinical quality improvement fails to deliver bottom-line results.储蓄错觉——为何临床质量改进未能带来实际经济效益。
N Engl J Med. 2011 Dec 29;365(26):e48. doi: 10.1056/NEJMp1111662. Epub 2011 Dec 14.
2
Delivering affordable cancer care in high-income countries.在高收入国家提供负担得起的癌症护理。
Lancet Oncol. 2011 Sep;12(10):933-80. doi: 10.1016/S1470-2045(11)70141-3.
3
Oncology management programs for payers and physicians: evaluating current models and diagnosing successful strategies for payers and physicians.
J Oncol Pract. 2011 May;7(3 Suppl):e46s-9s. doi: 10.1200/JOP.2011.000305.
4
Pathways, outcomes, and costs in colon cancer: retrospective evaluations in 2 distinct databases.结肠癌的途径、结果和成本:2 个不同数据库的回顾性评估。
Am J Manag Care. 2011 May;17 Suppl 5 Developing:SP45-52.
5
Bending the cost curve in cancer care.控制癌症治疗成本
N Engl J Med. 2011 May 26;364(21):2060-5. doi: 10.1056/NEJMsb1013826.
6
Strategic use of clinical pathways.临床路径的策略应用。
J Oncol Pract. 2011 Jan;7(1):54-6. doi: 10.1200/JOP.2010.000193.
7
Facilitators and barriers to implementing clinical care pathways.实施临床护理路径的促进因素和障碍。
BMC Health Serv Res. 2010 Jun 28;10:182. doi: 10.1186/1472-6963-10-182.
8
Cancer's next frontier: addressing high and increasing costs.癌症的下一个前沿领域:应对高昂且不断上涨的成本。
JAMA. 2010 Mar 17;303(11):1086-7. doi: 10.1001/jama.2010.283.
9
Future of cancer incidence in the United States: burdens upon an aging, changing nation.美国癌症发病率的未来:老龄化、不断变化的国家所面临的负担。
J Clin Oncol. 2009 Jun 10;27(17):2758-65. doi: 10.1200/JCO.2008.20.8983. Epub 2009 Apr 29.
10
Slowing the growth of health care costs--lessons from regional variation.减缓医疗保健成本的增长——区域差异带来的教训
N Engl J Med. 2009 Feb 26;360(9):849-52. doi: 10.1056/NEJMp0809794.